Topic
Vision Loss
36 published works
Drug Injury Watch
Syfovre Retinal Vaso-occlusive Vasculitis Case Report Involving 78-year Old Woman With Vision Loss
By Tom Lamb
She Went to the Local ER With Loss of Vision 11 Days After Receiving an Intravitreal Syfovre (Pegcetacoplan) Injection (Posted by Tom Lamb at Drug Injury Watch) In the March 2024…
Drug Injury Watch
Syfovre Eye Injury Cases: More Questions Than Answers One Year After First Reports
By Tom Lamb
Retinal Vasculitis After Syfovre Injections: Etiology is Still Unknown and Incidence Rate Remains Unclear (Posted by Tom Lamb at Drug Injury Watch) Syfovre (pegcetacoplan) was approved by the FDA in February…
Bench & Bar of Minnesota
I had a secret
By Minnesota State Bar Association
When I was in fourth grade I was shy and reserved. If you know me now, you might wonder how this was possible. But at the time, I was that…
FB Employment Discrimination Blog
Employers Should Not Turn A Blind Eye To Employees With Vision Disabilities
Picture this: a young adult gets a new job at an upscale fish market. The adult, let’s call him Sam, tells his supervisor that while he wears contacts, he has…
Kanoski Bresney Blog
Personal Injury Claims for Accidents Resulting in Blindness or Vision Loss
By Kanoski Bresney Personal Injury Attorneys
The ability to see is one ability that most people take for granted. Seeing allows us to drive, read, interact easily with computer screens and smartphones, and generally go about…
Drug Injury Watch
Beovu Drug Label Change in December 2021 Adds More Information About Vision Loss Side Effects
By Tom Lamb
Provides "risk factors and possible mechanism" for Beovu-related Retinal Vasculitis and Retinal Vascular Occlusion (Posted by Tom Lamb at Drug Injury Watch) We have finally seen the first Beovu drug label…
Drug Injury Watch
Elmiron-associated Retinopathy Risks Increased by (1) Longer Duration Use and (2) Higher Cumulative Dosage
By Tom Lamb
Elmiron Lawsuits Filed Because Drug Company Failed to Warn Before June 2020 About Elmiron-related Vision Loss Side Effects (Posted by Tom Lamb at Drug Injury Watch) We are handling Elmiron lawsuits…
Searcy Law Blog
Study Reveals Link Between Elmiron Exposure and Maculopathy
By Searcy Law
Elmiron (pentosan polysulfate sodium or PPS) is used to treat interstitial cystitis, a bladder condition that affects women more than men. Use of Elmiron has been linked to maculopathy, an…
Drug Injury Watch
Beovu Vision Loss Side Effects Continue to Plague Novartis, Ending 3 Key Clinical Trials in May 2021
By Tom Lamb
And Novartis "has yet to identify the root cause behind Beovu’s safety problem", According to a News Report (Posted by Tom Lamb at Drug Injury Watch) Starting back in February 2020,…
Drug Injury Watch
Elmiron Maculopathy Secondary to Pentosan Polysulfate (PPS) Toxicity: Medical Journal Article
By Tom Lamb
New Elmiron Study Suggests Established Maculopathy Patients Should be Asked About Possible Elmiron Use (Posted by Tom Lamb at Drug Injury Watch) Elmiron maculopathy secondary to pentosan polysulfate…